EquinYar Joints is a unique composition supporting the osteoarticular system and preventing degenerative changes. Thanks to a high bioavailability of nutrients, it quickly compensates mineral deficiencies and enriches the body with amino acids, that play an important role in the reconstruction and regeneration of joint cartilage. The active ingredients participate in type I and II collagen synthesis. Additionally, chondroitin stimulates the production of proteoglycans of joint cartilage, thus supporting its regeneration whilst glucosamine increase the production of synovia.
FDA approves Farxiga to treat type 2 diabetes
The U.S. FDA today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.